Select a Community
Are you sure you want to trigger topic in your Anconeus AI algorithm?
You are done for today with this topic.
Would you like to start learning session with this topic items scheduled for future?
| # | Code | QID |
Subspecialty
|
Topic
|
Complexity
|
Importance
|
|---|---|---|---|---|---|---|
| 1 | M1.PL.13.250 | 100766 |
Respiratory
|
Pulmonary Thromboembolism |
M 2
|
D
|
| 2 | M1.NE.14.77 | 106891 |
Neurology
|
Diseases of Myelination |
M 2
|
D
|
| 3 | M1.ON.16.4699 | 108389 |
Oncology
|
Thyroid Cancer |
M 2
|
D
|
| 4 | M1.BC.17.4708 | 108464 |
Biochemistry
|
Transcription |
M 1
|
D
|
| 5 | M1.BC.17.4766 | 109051 |
Biochemistry
|
Electron Transport Chain |
M 1
|
D
|
| 6 | M1.BC.17.4774 | 109101 |
Biochemistry
|
Citric Acid Cycle |
M 1
|
D
|
| 7 | M1.BC.17.4775 | 109104 |
Biochemistry
|
Pyruvate Dehydrogenase Complex |
M 3
|
D
|
| 8 | M1.EB.17.4750 | 108776 |
Embryology
|
Umbilical Cord and Remnants |
M 1
|
D
|
| 9 | M1.EB.17.4753 | 108834 |
Embryology
|
Fetal Circulation and Erythropoiesis |
M 3
|
D
|
| 10 | M1.EB.17.4767 | 109054 |
Embryology
|
Fetal Circulation and Erythropoiesis |
M 1
|
D
|
| 11 | M1.EB.17.4817 | 109390 |
Embryology
|
Tongue and Thyroid Development |
M 1
|
D
|
| 12 | M1.MC.17.4707 | 108442 |
Microbiology
|
Cutaneous and Subcutaneous Mycoses |
M 2
|
D
|
| 13 | M1.MC.17.4723 | 108525 |
Microbiology
|
Pseudomonas aeruginosa |
M 1
|
D
|
| 14 | M1.MC.17.4723 | 108540 |
Microbiology
|
Macrolides |
M 1
|
D
|
| 15 | M1.CV.17.4754 | 108867 |
Cardiovascular
|
Cardiac Tumors |
M 4
|
D
|
| 16 | M1.CV.17.4817 | 109377 |
Cardiovascular
|
Sites of Action for Cardiac Drugs |
M 1
|
D
|
| 17 | M1.CV.17.4867 | 109637 |
Cardiovascular
|
Myocardial Action Potential |
M 1
|
D
|
| 18 | M1.CV.17.4867 | 109648 |
Cardiovascular
|
Patent Ductus Arteriosus |
M 2
|
D
|
| 19 | M1.EC.17.4699 | 108293 |
Endocrine
|
Sheehan Syndrome |
M 2
|
D
|
| 20 | M1.EC.17.4707 | 108430 |
Endocrine
|
Sheehan Syndrome |
M 1
|
D
|
| 21 | M1.ON.17.4869 | 109739 |
Oncology
|
Benign Bone Tumors |
M 1
|
D
|
| 22 | M1.MK.17.4722 | 108536 |
MSK
|
Scleroderma |
M 1
|
D
|
| 23 | M1.PY.17.4726 | 108557 |
Psychiatry
|
Panic Disorder |
M 2
|
D
|
| 24 | M1.PY.17.4873 | 109988 |
Psychiatry
|
Methylphenidate (Ritalin) |
M 1
|
D
|
| 25 | M1.RL.17.4799 | 109341 |
Renal
|
Horseshoe Kidney |
M 1
|
D
|
| 26 | M1.AN.17.4740 | 108651 |
MSK
|
Brachial Plexus |
M 2
|
D
|
| 27 | M1.PL.17.4869 | 109792 |
Respiratory
|
Dead Spaces and Ventilation Rates |
M 1
|
D
|
| 28 | M1.RP.17.4868 | 109595 |
Reproductive
|
Antiandrogens |
M 3
|
D
|
| 29 | M1.PL.17.4695 | 107961 |
Respiratory
|
Dead Spaces and Ventilation Rates |
M 1
|
D
|
| 30 | M1.PL.17.4754 | 108712 |
Respiratory
|
Fat Embolus Syndrome |
M 2
|
D
|
| 31 | M1.HE.17.4873 | 109974 |
Hematology
|
Von Willebrand Disease |
M 2
|
D
|
| 32 | M1.RL.17.0 | 109761 |
Renal
|
Relative Concentrations along Proximal Tubule |
M 1
|
D
|
| 33 | M1.RL.17.4872 | 109882 |
Renal
|
Relative Concentrations along Proximal Tubule |
M 1
|
D
|
| 34 | M1.PY.17.4699 | 108377 |
Psychiatry
|
Other Pervasive Developmental Disorders |
M 2
|
D
|
| 35 | M1.PY.17.4707 | 108438 |
Psychiatry
|
Atypical Antidepressants |
M 3
|
D
|
| 36 | M1.PY.17.4755 | 108917 |
Psychiatry
|
Other Pervasive Developmental Disorders |
M 2
|
D
|
| 37 | M1.PY.17.4799 | 109348 |
Psychiatry
|
Monoamine Oxidase (MAO) Inhibitors |
M 1
|
D
|
| 38 | M1.PY.17.4868 | 109809 |
Psychiatry
|
Tourette Syndrome |
M 3
|
D
|
| 39 | M1.NE.17.4798 | 109178 |
Neurology
|
Cavernous Sinuses |
M 1
|
D
|
| 40 | M1.NE.17.4827 | 109431 |
Neurology
|
Wernicke-Korsakoff Syndrome |
M 1
|
D
|
| 41 | M1.NE.17.4799 | 109325 |
Neurology
|
Brainstem |
M 2
|
D
|
| 42 | M1.NE.17.4869 | 109768 |
Neurology
|
Wernicke-Korsakoff Syndrome |
M 1
|
D
|
| 43 | M1.NE.17.4870 | 109827 |
Neurology
|
Visual Pathway |
M 1
|
D
|
| 44 | M1.NE.17.4873 | 109978 |
Neurology
|
Neural Tube Defects |
M 2
|
D
|
| 45 | M1.MK.17.4722 | 108534 |
MSK
|
Paget Disease of Bone |
M 2
|
D
|
| 46 | M1.ON.17.4874 | 109998 |
Oncology
|
Tumor Markers |
M 1
|
D
|
| 47 | M1.ON.17.4798 | 109235 |
Oncology
|
Esophageal Cancer |
M 2
|
D
|
| 48 | M1.MK.17.4722 | 108545 |
MSK
|
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) |
M 2
|
D
|
| 49 | M1.MK.17.4740 | 108654 |
MSK
|
Polymyositis / Dermatomyositis |
M 1
|
D
|
| 50 | M1.NE.17.4695 | 108019 |
Neurology
|
Wernicke-Korsakoff Syndrome |
M 2
|
D
|
| 51 | M1.NE.17.4719 | 108509 |
Neurology
|
Visual Pathway |
M 3
|
D
|
| 52 | M1.MC.17.4798 | 109224 |
Microbiology
|
Viral Envelopes |
M 1
|
D
|
| 53 | M1.MC.17.4798 | 109260 |
Microbiology
|
Flukes (Trematodes) |
M 3
|
D
|
| 54 | M1.MC.17.4754 | 108866 |
Microbiology
|
Neisseria gonorrhoeae |
M 3
|
D
|
| 55 | M1.MC.17.4754 | 108953 |
Microbiology
|
Prions |
M 2
|
D
|
| 56 | M1.MC.17.4754 | 108960 |
Microbiology
|
Rubella Virus |
M 2
|
D
|
| 57 | M1.EC.17.4868 | 109708 |
Endocrine
|
Prolactin |
M 3
|
D
|
| 58 | M1.EC.17.4871 | 109850 |
Endocrine
|
Waterhouse-Friderichsen Syndrome |
M 1
|
D
|
| 59 | M1.EC.17.4869 | 109863 |
Endocrine
|
Pituitary Apoplexy |
M 3
|
D
|
| 60 | M1.PH.17.4699 | 108317 |
Pharmacology
|
Drug Excretion |
M 3
|
D
|
| 61 | M1.PH.17.4868 | 109705 |
Pharmacology
|
Autonomic Pathways |
M 3
|
D
|
| 62 | M1.GI.17.4753 | 108848 |
Gastrointestinal
|
Angiodysplasia |
M 2
|
D
|
| 63 | M1.GI.17.4768 | 109055 |
Gastrointestinal
|
Hepatitis |
M 3
|
D
|
| 64 | M1.GI.17.4800 | 109281 |
Gastrointestinal
|
Alcoholic Liver Disease |
M 2
|
D
|
| 65 | M1.GI.17.4868 | 109706 |
Gastrointestinal
|
Pancreatic Enzymes |
M 1
|
D
|
| 66 | M1.ON.17.4717 | 108500 |
Oncology
|
Non-Hodgkin Lymphoma |
M 1
|
D
|
| 67 | M1.ON.17.4722 | 108544 |
Oncology
|
Metastasis |
M 2
|
D
|
| 68 | M1.ON.17.4752 | 108766 |
Oncology
|
Testicular Tumors |
M 2
|
D
|
| 69 | M1.MC.17.4725 | 108554 |
Microbiology
|
Metronidazole |
M 1
|
D
|
| 70 | M1.MC.17.4725 | 108556 |
Microbiology
|
Tapeworms (Cestodes) |
M 2
|
D
|
| 71 | M1.MC.17.4727 | 108558 |
Microbiology
|
Rubeola (Measles) |
M 1
|
D
|
| 72 | M1.EB.17.4867 | 109636 |
Embryology
|
Changes in the Elderly |
M 1
|
D
|
| 73 | M1.EB.17.4869 | 109718 |
Embryology
|
Placental Components |
M 1
|
D
|
| 74 | M1.BC.17.4799 | 109298 |
Biochemistry
|
Amino Acids |
M 3
|
D
|
| 75 | M1.MC.17.4695 | 108056 |
Microbiology
|
Special Culture Requirements |
M 1
|
D
|
| 76 | M1.MC.17.4707 | 108433 |
Microbiology
|
Special Culture Requirements |
M 2
|
D
|
| 77 | M1.BC.17.4723 | 108552 |
Biochemistry
|
Ethanol Metabolism |
M 3
|
D
|
| 78 | M1.BC.17.4753 | 108851 |
Biochemistry
|
Lipoprotein Disorders |
M 1
|
D
|
| 79 | M1.BC.17.4754 | 108937 |
Biochemistry
|
Amino Acids |
M 1
|
D
|
| 80 | M1.BC.17.4766 | 109046 |
Biochemistry
|
Karyotyping |
M 2
|
D
|
| 81 | M1.MC.14.31 | 101152 |
Microbiology
|
Helicobacter pylori |
M 3
|
D
|
| 82 | M1.MC.13.10 | 101469 |
Microbiology
|
Parvovirus B19 |
M 1
|
D
|
| 83 | M1.EC.13.57 | 100573 |
Endocrine
|
Hyperaldosteronism / Conn Syndrome |
M 2
|
D
|
| 84 | M1.GI.13.76 | 101133 |
Gastrointestinal
|
Peptic Ulcer Disease |
M 2
|
D
|
| 85 | M1.GI.13.122 | 100638 |
Gastrointestinal
|
Gastritis |
M 4
|
D
|
| 86 | M1.MC.14.56 | 100859 |
Microbiology
|
Isoniazid |
M 3
|
D
|
| 87 | M1.BC.17.4766 | 109045 |
Biochemistry
|
Microarrays |
M 1
|
D
|
| 88 | M1.BC.17.4755 | 108874 |
Biochemistry
|
Metabolism Overview |
M 1
|
D
|
| 89 | M1.EB.17.4799 | 109317 |
Embryology
|
Lung Development |
M 2
|
D
|
| 90 | M1.BC.17.4798 | 109219 |
Biochemistry
|
Sorbitol |
M 1
|
D
|
| 91 | M1.BC.17.4798 | 109220 |
Biochemistry
|
Metabolism of Exercise and Starvation |
M 1
|
D
|
| 92 | M1.BC.17.4867 | 109597 |
Biochemistry
|
Galactose Metabolism |
M 1
|
D
|
| 93 | M1.BC.17.4878 | 109686 |
Biochemistry
|
Universal Electron Acceptors |
M 1
|
D
|
| 94 | M1.MC.17.4695 | 108037 |
Microbiology
|
Vibrio parahaemolyticus / vulnificus |
M 2
|
D
|
| 95 | M1.MC.17.4725 | 108566 |
Microbiology
|
Influenza Viruses |
M 1
|
D
|
| 96 | M1.MC.17.4723 | 108528 |
Microbiology
|
Rifamycins |
M 1
|
D
|
| 97 | M1.ON.17.4753 | 108771 |
Oncology
|
Chronic Myeloid Leukemia (CML) |
M 3
|
D
|
| 98 | M1.ON.17.4751 | 108789 |
Oncology
|
Platinum Analogs |
M 1
|
D
|
| 99 | M1.ON.17.4751 | 108803 |
Oncology
|
Antitumor Antibiotics |
M 3
|
D
|
| 100 | M1.ON.17.4747 | 108672 |
Oncology
|
Oncogenic Viruses |
M 1
|
D
|
| 101 | M1.ON.17.4754 | 108719 |
Oncology
|
Alkylating Agents |
M 1
|
D
|
| 102 | M1.GI.17.4768 | 109056 |
Gastrointestinal
|
Dubin-Johnson / Rotor Syndrome |
M 2
|
D
|
| 103 | M1.GI.17.4798 | 109212 |
Gastrointestinal
|
Peutz-Jeghers Syndrome |
M 1
|
D
|
| 104 | M1.GI.17.4753 | 108849 |
Gastrointestinal
|
Gastric Secretion |
M 1
|
D
|
| 105 | M1.PH.17.4798 | 109231 |
Pharmacology
|
Efficacy vs. Potency |
M 1
|
D
|
| 106 | M1.IM.17.4707 | 108446 |
Immunology
|
Structure and Function of MHC |
M 1
|
D
|
| 107 | M1.IM.17.4754 | 108947 |
Immunology
|
Recombinant Cytokines |
M 3
|
D
|
| 108 | M1.MC.17.4768 | 109057 |
Microbiology
|
Coronavirus |
M 1
|
D
|
| 109 | M1.MC.17.4768 | 109075 |
Microbiology
|
Protease Inhibitors |
M 1
|
D
|
| 110 | M1.MC.17.4754 | 108829 |
Microbiology
|
Bacillus cereus |
M 1
|
D
|
| 111 | M1.MC.17.4796 | 109176 |
Microbiology
|
Klebsiella |
M 1
|
D
|
| 112 | M1.MC.17.4800 | 109286 |
Microbiology
|
Leptospira interrogans |
M 2
|
D
|
| 113 | M1.MC.17.4800 | 109287 |
Microbiology
|
Haemophilus influenzae |
M 2
|
D
|
| 114 | M1.MC.17.4799 | 109295 |
Microbiology
|
Poliovirus |
M 1
|
D
|
| 115 | M1.MC.17.4799 | 109307 |
Microbiology
|
Rotavirus |
M 2
|
D
|
| 116 | M1.MC.17.4822 | 109423 |
Microbiology
|
Hepatitis C Virus |
M 3
|
D
|
| 117 | M1.MC.17.4867 | 109629 |
Microbiology
|
Bacterial Genetics |
M 1
|
D
|
| 118 | M1.MC.17.4868 | 109731 |
Microbiology
|
Coronavirus |
M 1
|
D
|
| 119 | M1.MC.17.4868 | 109732 |
Microbiology
|
Trimethoprim |
M 1
|
D
|
| 120 | M1.EC.17.4726 | 108580 |
Endocrine
|
Neuroblastoma |
M 2
|
D
|
| 121 | M1.EC.17.4750 | 108778 |
Endocrine
|
Parathyroid Hormone (PTH) |
M 1
|
D
|
| 122 | M1.EC.17.4798 | 109223 |
Endocrine
|
Signaling Pathways of Endocrine Hormones |
M 1
|
D
|
| 123 | M1.EC.17.4867 | 109602 |
Endocrine
|
Hypothalamic-Pituitary Axis |
M 1
|
D
|
| 124 | M1.NE.17.4753 | 108827 |
Neurology
|
Eye Anatomy |
M 3
|
D
|
| 125 | M1.MK.17.4754 | 108931 |
Dermatology
|
Staphylococcal Scalded Skin Syndrome (SSSS) |
M 1
|
D
|
| 126 | M1.MK.17.4768 | 109076 |
Dermatology
|
Bullous Pemphigoid |
M 1
|
D
|
| 127 | M1.ON.17.4798 | 109262 |
Oncology
|
Cervical Cancer |
M 2
|
D
|
| 128 | M1.ON.17.4869 | 109748 |
Oncology
|
Parathyroid Adenoma |
M 1
|
D
|
| 129 | M1.GI.17.4753 | 108847 |
Gastrointestinal
|
Alpha-1 Antitrypsin Deficiency |
M 2
|
D
|
| 130 | M1.ON.17.4707 | 108448 |
Oncology
|
Oncogenes |
M 2
|
D
|
| 131 | M1.MK.17.4722 | 108529 |
Dermatology
|
Vitiligo |
M 1
|
D
|
| 132 | M1.MK.17.4722 | 108531 |
Dermatology
|
Seborrheic Keratosis |
M 2
|
D
|
| 133 | M1.ON.17.4867 | 109646 |
Oncology
|
Hairy Cell Leukemia (HCL) |
M 2
|
D
|
| 134 | M1.NE.17.4870 | 109826 |
Neurology
|
Lewy Body Dementia |
M 3
|
D
|
| 135 | M1.NE.17.4798 | 109225 |
Neurology
|
Seizures |
M 2
|
D
|
| 136 | M1.RL.17.4751 | 108791 |
Renal
|
Bladder / Urethra Anatomy |
M 1
|
D
|
| 137 | M1.RL.17.4872 | 109899 |
Renal
|
Kidney Endocrine Functions |
M 2
|
D
|
| 138 | M1.RL.17.4830 | 109476 |
Renal
|
Glomerular Filtration Barrier |
M 1
|
D
|
| 139 | M1.RL.17.4868 | 109694 |
Renal
|
Glucose Clearance |
M 1
|
D
|
| 140 | M1.RP.17.4754 | 108714 |
Reproductive
|
Mastitis |
M 1
|
D
|
| 141 | M1.HE.17.4868 | 109814 |
Hematology
|
Bernard-Soulier Disease |
M 1
|
D
|
| 142 | M1.PL.17.4753 | 108898 |
Respiratory
|
Sinusitis |
M 3
|
D
|
| 143 | M1.PL.17.4768 | 109070 |
Respiratory
|
Oxygen Transport and Hemoglobin |
M 1
|
D
|
| 144 | M1.HE.17.4708 | 108477 |
Hematology
|
Bernard-Soulier Disease |
M 2
|
D
|
| 145 | M1.HE.17.4868 | 109703 |
Hematology
|
Autoimmune Hemolytic Anemia |
M 2
|
D
|
| 146 | M1.HE.17.4868 | 109711 |
Hematology
|
Methemoglobinemia |
M 3
|
D
|
| 147 | M1.RP.17.4884 | 110014 |
Reproductive
|
Testosterone |
M 4
|
D
|
| 148 | M1.RP.17.4869 | 109843 |
Reproductive
|
Endometriosis |
M 2
|
D
|
| 149 | M1.RP.17.4798 | 109222 |
Reproductive
|
Oogenesis |
M 1
|
D
|
| 150 | M1.NE.17.4798 | 109257 |
Neurology
|
Action Potential Conduction |
M 1
|
D
|